News

Pure Global launches innovative MedTech resource centre

The platform amalgamates data from over 30 markets, providing various tools to navigate regulatory requirements, monitor medical device registrations, and analyse clinical trials utilising AI-driven insights.

Published on:
September 13, 2024

This article was originally published on IT Brief Asia.

Pure Global has introduced the Pure Global Resource Centre, a comprehensive platform to accelerate market access for MedTech companies and streamline their go-to-market strategies. The platform amalgamates data from over 30 markets, providing various tools to navigate regulatory requirements, monitor medical device registrations, and analyse clinical trials utilising AI-driven insights.

With the complexity of managing diverse global markets, the Pure Global Resource Center offers extensive data on regulatory requirements, clinical trials, and medical device registrations. Key features of the platform include a comprehensive database that provides access to over 4 million medical device registrations and detailed clinical trial data. This database offers insights into study sites, sponsors, diseases, and study stages.

The platform includes tools for tracking the latest regulatory changes and managing global product registrations to assist with regulatory compliance. It also features a translation platform that supports over 20 languages, facilitating efficient global communication. The platform leverages AI to analyse regulatory updates, enhancing compliance and decision-making processes.

Phyllis Meng, CEO and Co-founder of Pure Global, said, "The Pure Global Resource Center combines an unparalleled level of depth and breadth of data with market insights tailored specifically for MedTech companies. By combining the power of our platform with the expertise of our local market specialists, Pure Global can guide clients in identifying the most efficient and effective routes for bringing their products to the market."

The platform's customisable solutions enable organisations to modify specific features or opt for full on-premises deployments, catering to diverse needs. The solutions range from internal certification management to global product tracking.

Additionally, the Resource Centre utilises local market specialists' insights to guide clients' strategic market entry, ensuring informed decision-making tailored to specific regional requirements. The platform's AI-powered analysis further aids in understanding and navigating complex regulatory frameworks.

Looking ahead, Pure Global plans to showcase the Pure Global Resource Centre at the RAPS Convergence 2024 event in Long Beach, allowing industry professionals to explore the platform's capabilities firsthand. As a company specialising in next-generation solutions for MedTech firms looking to expand globally, Pure Global is committed to continuously enhancing the Resource Centre based on client feedback and technological advancements.

By deepening the integration of artificial intelligence and expanding platform functionalities, Pure Global aims to address the challenges of global market access better, helping clients make informed decisions, refine market entry strategies, and navigate the complexities of international standards with the support of expert guidance from local market specialists.

Subscribe to newsletter
Subscribe to receive the latest blog posts to your inbox every week.
By subscribing, you agree to our Terms and Conditions.
Thank you for subscribing!
Oops! Something went wrong while submitting the form.
Read more

Latest News

Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.

Regulatory Update
January 29, 2025

Wrapping up January 2025, medical device regulatory developments include new forms for NBs in Europe, new PMS guidance in the UK, an expedited approval partnership between China and Malaysia, and warnings of supply chain disruptions for pediatric patients in the US.

Regulatory Update
January 23, 2025

Medical device regulatory developments from the US and Thailand include: final FDA guidance on modular review for premarket approval applications and humanitarian device exemptions, and new expedited regulatory routes for low-risk devices and chronic disease prevention devices in Thailand.

Regulatory Update
January 16, 2025

This week, we are reporting on medical device regulatory updates from Canada, Europe, Brazil, and China. China's NMPA released registration review timelines, clarification on MDR and IVDR vigilance terms is now available, and Health Canada updated validation rules for non-eCTD transactions.

To kick off 2025, we bring you a round up of medical device regulatory updates from across Europe and the US, including a new position paper from TEAM-NB on MDR certification processes and numerous guidance updates from the US FDA.

Contact us
Request information

Let's Talk,
Anywhere You Are.

Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.

Our closest representative will get back to you within 24 hours.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Latest Blog Content

Explore our collection of articles, success stories, and regulatory updates, designed to help you take your product global.

Blog Article

The official IVDR transition period is here. IVDR expert Dr. Oliver Eikenberg discusses how IVD manufacturers should take action, starting with how to implement IVDR QMS requirements for the May 2025 deadline.

Kuala Lumpur Malaysia Skyline
Blog Article
Pure Global Team attends IMDEC 2024 in Malaysia

Pure Global participated in IMDEC 2024 in Kuala Lumpur to discuss the latest advancements in medical technology, regulatory efficiency, and the role of AI in transforming the industry. Highlights included updates from the Malaysian Medical Device Authority (MDA) that showcased their commitment to driving regional leadership in medical device regulation and innovation.

Pure Global 2024 Year in Review
Blog Article
Pure Global 2024 Year in Review

As 2024 comes to a close, Pure Global proudly reflects on a transformative year marked by substantial growth, cutting-edge innovation, and impactful collaborations.

Risk increases compliance chalenges under IVDR
Blog Article
What are the challenges under IVDR?

IVD manufacturers cite the new classification system, detailed definitions for intended purposes, and the need for verification of clinical evidence as key challenges under the IVDR.